![Jerzy Gruhn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jerzy Gruhn
Corporate Officer/Principal chez European Association For The Study of Diabetes
Postes actifs de Jerzy Gruhn
Sociétés | Poste | Début | Fin |
---|---|---|---|
European Association For The Study of Diabetes | Corporate Officer/Principal | - | - |
Historique de carrière de Jerzy Gruhn
Anciens postes connus de Jerzy Gruhn
Sociétés | Poste | Début | Fin |
---|---|---|---|
Novo Nordisk, Inc.
![]() Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | President | 01/01/2008 | - |
Pharmaceutical Research & Manufacturers of America
![]() Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Directeur/Membre du Conseil | 21/12/2010 | - |
NOVO NORDISK A/S | Corporate Officer/Principal | - | - |
Formation de Jerzy Gruhn
University of Warsaw | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 3 |
Danemark | 2 |
Allemagne | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
President | 1 |
Director/Board Member | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
NOVO NORDISK A/S | Health Technology |
Entreprise privées | 3 |
---|---|
Novo Nordisk, Inc.
![]() Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
European Association For The Study of Diabetes | |
Pharmaceutical Research & Manufacturers of America
![]() Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
- Bourse
- Insiders
- Jerzy Gruhn
- Expérience